bemegride has been researched along with Hepatolenticular Degeneration in 1 studies
Bemegride: A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, T | 1 |
| Miyasaka, M | 1 |
| Moriya, H | 1 |
| Fukuzawa, H | 1 |
| Shimazono, Y | 1 |
1 other study available for bemegride and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Photic and bemegride activation of triphasic waves in portal-systemic encephalopathy.
Topics: Adolescent; Adult; Bemegride; Electroencephalography; Hepatic Encephalopathy; Hepatolenticular Degen | 1971 |